The Stanley Brothers began breeding for high CBD cannabis strains in 2009, shortly after their entrance into the medical marijuana industry. Their purposes for doing so were to find more benefits from the plant's compounds, specifically for patients who didn't benefit from psycho-activity; as well as for the potential anti-tumor properties suggested by many preclinical studies. After meeting the Figi family in early 2012, and discovering 5 year old Charlotte Figi's dramatic success in her battle with epilepsy, the Stanley's CBD project became known as the Charlotte's Web™ breeding project. To date, there are several phenotypic strains that have emerged from the CW project which have low enough THC to be considered Hemp. Currently, only certain phenotypes are commonly used for the CBD infused into Charlotte's Web Hemp Products™, due to the high success rate of these specific cannabinoid profiles in intractable epilepsy.
The Charlotte's Web™ product line is currently dedicated to the life and death cases of intractable epilepsy which continue to fill our national waiting list. Soon though, the list will be satisfied and the product line will be expanded to include products for all who may benefit from CW products.